Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$1.89 - $2.93 $7,749 - $12,013
-4,100 Reduced 22.09%
14,461 $30,000
Q4 2022

Feb 07, 2023

BUY
$2.48 - $3.43 $4,761 - $6,585
1,920 Added 11.54%
18,561 $49,000
Q3 2022

Nov 09, 2022

BUY
$3.14 - $6.43 $11,721 - $24,003
3,733 Added 28.92%
16,641 $54,000
Q2 2022

Aug 05, 2022

BUY
$4.74 - $8.15 $61,183 - $105,200
12,908 New
12,908 $63,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $437M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.